Immunomodulatory effect of continuous venovenous hemofiltration during sepsis: Preliminary data

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Servillo, Giuseppe ^a   Vargas, Maria ^a   Pastore, Antonio ^a   Procino, Alfredo ^a   Iannuzzi, Michele ^a   Capuano, Alfredo ^a   Memoli, Andrea ^a   Riccio, Eleonora ^a   Memoli, Bruno ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS HEMOFILTRATION; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOMODULATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEPSIS; SEPTIC SHOCK; SUBSTITUTION THERAPY; THERAPY EFFECT; ACUTE KIDNEY INJURY; CLINICAL TRIAL; HEMOFILTRATION; IMMUNOLOGY; MIDDLE AGED; PILOT STUDY; PROCEDURES; TREATMENT OUTCOME; VERY ELDERLY; METHODOLOGY;

ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMOFILTRATION; HUMANS; IMMUNOMODULATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PILOT PROJECTS; SEPSIS; TREATMENT OUTCOME;

EID: 84881503825     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/108951     Document Type: Article

References (25)

1. Angus D. C., Linde-Zwirble W. T., Lidicker J., Clermont G., Carcillo J., Pinsky M. R., Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 2001 29 7 1303 1310 2-s2.0-0034958947 (Pubitemid 32641789)
2. Beale R., Reinhart K., Brunkhorst F. M., Promoting global research excellence in severe sepsis (PROGRESS): lessons from an international sepsis study. Infectio 2009 37 3 222 232
3. Alberti C., Brun-Buisson C., Burchardi H., Martin C., Goodman S., Artigas A., Sicignano A., Palazzo M., Moreno R., Boulmé R., Lepage E., Le Gall J., Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Medicine 2002 28 2 108 121 2-s2.0-0036213966 10.1007/s00134-001-1143-z (Pubitemid 34293822)
4. Silva E., Pedro Mde A., Sogayar A. C., Brasilian sepsis epidemiological study (BASES study). Critical Care Medicine 2004 8 4 R251 R260
5. Pinsky M. R., Vincent J.-L., Deviere J., Alegre M., Kahn R. J., Dupont E., Serum cytokine levels in human septic shock; Relation to multiple-system organ failure and mortality. Chest 1993 103 2 565 575 2-s2.0-0027457502 (Pubitemid 23070764)
6. Bone R. C., Grodzin C. J., Balk R. A., Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997 112 1 235 243 2-s2.0-0030843156 (Pubitemid 27343624)
7. Ronco C., Bonello M., Bordoni V., Ricci Z., D'Intini V., Bellomo R., Levin N. W., Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purification 2004 22 1 164 174 2-s2.0-0942300683 10.1159/000074937 (Pubitemid 38142302)
8. Grootendorst A. F., The potential role of hemofiltration in the treatment of patients with septic shock and multiple organ dysfunction syndrome. Advances in Renal Replacement Therapy 1994 1 2 176 184 2-s2.0-0028476490
9. Cole L., Bellomo R., Hart G., Journois D., Davenport P., Tipping P., Ronco C., A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Critical Care Medicine 2002 30 1 100 106 2-s2.0-0036154952 (Pubitemid 34112184)
10. Ronco C., Bellomo R., Homel P., Brendolan A., Dan M., Piccinni P., La Greca G., Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. The Lancet 2000 355 9223 26 30 2-s2.0-0034222937 (Pubitemid 30416991)
11. Dellinger R. P., Carlet J. M., Masur H., Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Medicine 2008 34 17 60
12. Ertel W., Kremer J.-P., Kenney J., Steckholzer U., Jarrar D., Trentz O., Schildberg F. W., Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 1995 85 5 1341 1347 2-s2.0-0028937425
13. Cavaillon J.-M., Munoz C., Fitting C., Misset B., Carlet J., Circulating cytokines: the tip of the iceberg? Circulatory Shock 1992 38 2 145 152 2-s2.0-0026648849
14. Dellinger R. P., Carlet J. M., Masur H., Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Critical Care Medicine 2004 32 10 858 873 2-s2.0-5644220075 (Pubitemid 38344143)
15. Metnitz P. G. H., Moreno R. P., Almeida E., Jordan B., Bauer P., Campos R. A., Iapichino G., Edbrooke D., Capuzzo M., Le Gall J.-R., SAPS 3-From evaluation of the patient to evaluation of the intensive care unit. Part 1: objectives, methods and cohort description. Intensive Care Medicine 2005 31 10 1336 1344 2-s2.0-26444464890 10.1007/s00134-005-2762-6 (Pubitemid 41437727)
16. Moreno R. P., Metnitz P. G. H., Almeida E., Jordan B., Bauer P., Campos R. A., Iapichino G., Edbrooke D., Capuzzo M., Le Gall J.-R., SAPS 3-From evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Medicine 2005 31 10 1345 1355 2-s2.0-26444506063 10.1007/s00134-005-2763-5 (Pubitemid 41437728)
17. Vincent J.-L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., Reinhart C. K., Suter P. M., Thijs L. G., The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Medicine 1996 22 7 707 710 2-s2.0-0030015661 10.1007/s001340050156 (Pubitemid 26254283)
18. Memoli B., Libetta C., Rampino T., Dal Canton A., Conte G., Scala G., Ruocco M. R., Andreucci V. E., Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells. Kidney International 1992 42 2 320 326 2-s2.0-0026770930
19. Bellomo R., Tipping P., Boyce N., Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Critical Care Medicine 1993 21 4 522 526 2-s2.0-0027417688 (Pubitemid 23121799)
20. Honoré P. M., Joannes-Boyau O., Gressens B., Blood and plasma treatments: the rationale of high-volume hemofiltration. Contributions to Nephrology 2007 156 387 395 2-s2.0-34247608402 10.1159/0000102129
21. Sander A., Armbruster W., Sander B., Daul A. E., Lange R., Peters J., Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF α plasma concentrations. Intensive Care Medicine 1997 23 8 878 884 2-s2.0-0030821831 10.1007/ s001340050425 (Pubitemid 27417692)
22. Ronco C., Tetta C., Mariano F., Wratten M. L., Bonello M., Bordoni V., Cardona X., Inguaggiato P., Pilotto L., D'Intini V., Bellomo R., Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artificial Organs 2003 27 9 792 801 2-s2.0-10744222374 10.1046/j.1525-1594.2003.07289.x (Pubitemid 37108619)
23. Horner C., Schuster S., Plachy J., Hemofitration and immune response in severe sepsis. Journal of Surgical Research 2007 142 59 65 (Pubitemid 47267993)
24. Toft P., Brix-Christensen V., Baech J., Effect of hemofiltration and sepsis on chemotaxis of granulacyties and release of IL-8 and IL-10. Acta Anaesthesiologica Scandinavica 2002 46 2 138 144 (Pubitemid 34250774)
25. De Vriese A. S., Colardyn F. A., Philippé J. J., Vanholder R. C., De Sutter J. H., Lameire N. H., Cytokine removal during continuous hemofiltration in septic patients. Journal of the American Society of Nephrology 1999 10 4 846 853 2-s2.0-0033022529 (Pubitemid 29149536)